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items might not apply to an individual manuscript, but all fields must be completed for clarity. 
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research 
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`    Experimental design
1.   Sample size
Describe how sample size was determined. No sample size calculation was performed because the size of the effect was 
unknown. Experiments were repeated (biological replicates) to confirm results, or 
done in duplicate as in Figs. 4b, 4d.
2.   Data exclusions
Describe any data exclusions. No data was excluded from the analyses. 
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
All findings have been replicated  twice (western blots and PhosphorImager 
analyses), or thrice (spot viability assays).
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Not relevant to the current study. There were no experimental groups.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
The experimenter was aware of the identity of the samples being analyzed. 
Blinding was not relevant in the current study since the Figures show the raw data 
from the experiments and thus the reader can directly assess the accuracy of the 
interpretations by the experimenter.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Commercial Prism software. Otherwise, all publicly available software: 
BLAST, PSIBLAST, RPSBLAST, HHpred, HMMER3, KALIGN, FastTree, MaxQuant, 
DaliLite, PyMol 1.8.2.0 (Open Source). The central conclusion of the MS is 
supported by all publicly available software.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
No restrictions.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
Peroxidase Anti-Peroxidase Soluble Complex (PAP; used to detect Protein A, Sigma, 
# P1291). Anti-Flag M2 (Sigma # F-1804), anti-TAP (Thermo Fisher # CAB1001, and 
anti-HA 3F10 (Roche/Sigma # 12013819001). Antibodies were validated by using 
untagged or untransformed controls. Anti-Rpl32 and Rpl3 were a gift from 
Jonathan Warner. These have been validated by immunoblotting sucrose gradient 
ribosomal fractions as well as comparing mobility on gels with tagged controls.
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. All yeast cell line sources are listed in Table 1.  293T cells used for the expression 
and purification of hAnkzf1 were from ATCC (DTC#264).
b.  Describe the method of cell line authentication used. All yeast cell lines were confirmed by selection on drop out media or genomic PCR, 
or temperature-sensitivity, if the strain was temperature sensitive.  
ATCC certification for 293T cells.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
293T cells used for expression and purification of hAnkzf1 tested negative for 
mycoplasma contamination
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
No animals were used.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
No human research participants.
